Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rogers Corp (NY: ROG )

186.27 USD +4.19 (+2.30%)
Official Closing Price Updated: 7:00 PM EDT, May 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,694
Open 184.80
Bid (Size) 157.23 (1)
Ask (Size) 217.50 (1)
Prev. Close 182.08
Today's Range 184.17 - 186.99
52wk Range 92.01 - 206.13
Shares Outstanding 18,712,154
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Genentech to Present Data From One of the Most Comprehensive Oncology Portfolios at the 2021 ASCO Annual Meeting Showcasing Advancements for People Living With Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that new data from clinical trials of 19 approved and investigational medicines across 20 cancer types will be... 
From Business Wire News Releases
Rogers Corporation Reports First Quarter 2021 Results
Releasing the quarterly/yearly numbers 
From Business Wire News Releases

Performance

YTD
+22.47%
+22.47%
1 Month
-2.67%
-2.67%
3 Month
+3.91%
+3.91%
6 Month
+34.34%
+34.34%
1 Year
+90.03%
+90.03%

More News

Read More
Rogers Appoints Ram Mayampurath Chief Financial Officer
From Business Wire News Releases
FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech’s Tecentriq for Previously Untreated Metastatic Bladder Cancer
From Business Wire News Releases
FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech’s Tecentriq for PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
From Business Wire News Releases
New Data for Genentech’s Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis
From Business Wire News Releases
Recap: Rogers Q1 Earnings
Tags BZI/Recaps ROG Benzinga
From Benzinga
Rogers Schedules Q1 2021 Earnings Call for April 29, 2021
From Business Wire News Releases
Genentech’s Evrysdi Continues to Improve Motor Function and Survival in Babies With Type 1 Spinal Muscular Atrophy (SMA)
From Business Wire News Releases
FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
From Business Wire News Releases
New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expanding Neuroscience Portfolio
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.